# LiveOne, Inc.: overview LVO · Nasdaq · CIK 1491419 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Mar 31 Pages: [Overview](/companies/lvo.md) · [Financials](/companies/lvo/financials.md) · [Filings](/companies/lvo/filings.md) · [Insiders](/companies/lvo/insiders.md) Latest reported revenue: [$19.4m](/filings/0001437749-26-028046.md) for Q1 FY2027, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001437749-26-028046). ## Last eight quarters | Line item | Unit | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [32.6](/filings/0001437749-25-035107.md) | [29.4](/filings/0001437749-26-004111.md) | [19.3 d](/filings/0001437749-26-021987.md) | [19.2](/filings/0001437749-26-028046.md) | [18.8](/filings/0001437749-25-035107.md) | [20.3](/filings/0001437749-26-004111.md) | [18.9 d](/filings/0001437749-26-021987.md) | [19.4](/filings/0001437749-26-028046.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(4.3%)](/filings/0001437749-25-035107.md) | [(17.4%)](/filings/0001437749-26-004111.md) | [(55.8%) d](/filings/0001437749-26-021987.md) | [(21.0%)](/filings/0001437749-26-028046.md) | [(24.4%)](/filings/0001437749-25-035107.md) | [(9.6%)](/filings/0001437749-26-004111.md) | [(26.0%) d](/filings/0001437749-26-021987.md) | [(19.0%)](/filings/0001437749-26-028046.md) | | Net margin | % | [(5.7%)](/filings/0001437749-25-035107.md) | [(17.8%)](/filings/0001437749-26-004111.md) | [(54.2%) d](/filings/0001437749-26-021987.md) | [(18.7%)](/filings/0001437749-26-028046.md) | [(29.5%)](/filings/0001437749-25-035107.md) | [(20.1%)](/filings/0001437749-26-004111.md) | [(41.0%) d](/filings/0001437749-26-021987.md) | [(13.4%)](/filings/0001437749-26-028046.md) | | Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Free cash flow | $m | [5.2 d](/filings/0001437749-25-035107.md) | [2.7 d](/filings/0001437749-26-004111.md) | [(5.2) d](/filings/0001437749-26-021987.md) | [(4.1)](/filings/0001437749-26-028046.md) | [(4.0) d](/filings/0001437749-25-035107.md) | [(2.9) d](/filings/0001437749-26-004111.md) | [(2.7) d](/filings/0001437749-26-021987.md) | [(2.9)](/filings/0001437749-26-028046.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL not reported. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2022 (2022-03-31) | FY2023 (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) | FY2026 (2026-03-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [117](/filings/0001213900-23-053022.md) | [99.6](/filings/0001437749-24-021725.md) | [118](/filings/0001437749-25-022739.md) | [114](/filings/0001437749-26-021987.md) | [77.1](/filings/0001437749-26-021987.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(32.3%)](/filings/0001213900-23-053022.md) | [(2.2%)](/filings/0001437749-24-021725.md) | [(3.9%)](/filings/0001437749-25-022739.md) | [(15.8%)](/filings/0001437749-26-021987.md) | [(20.1%)](/filings/0001437749-26-021987.md) | | Net margin | % | [(37.5%)](/filings/0001213900-23-053022.md) | [(10.1%)](/filings/0001437749-24-021725.md) | [(10.1%)](/filings/0001437749-25-022739.md) | [(16.4%)](/filings/0001437749-26-021987.md) | [(27.2%)](/filings/0001437749-26-021987.md) | | Diluted EPS | $ per share | [(0.56)](/filings/0001213900-23-053022.md) | [(0.12)](/filings/0001213900-23-053022.md) | not reported | not reported | not reported | | Free cash flow | $m | [(12.9)](/filings/0001213900-23-053022.md) | [(6.3)](/filings/0001437749-24-021725.md) | [3.8](/filings/0001437749-25-022739.md) | [3.3](/filings/0001437749-26-021987.md) | [(13.7)](/filings/0001437749-26-021987.md) | - Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/lvo/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.6m | 401,004 | | Added +27,932 | | [FMR LLC](/funds/315066.md) | 2026-06-30 | $2.3m | 366,664 | | Reduced −23,000 | | [KENNEDY CAPITAL MANAGEMENT LLC](/funds/884589.md) | 2026-06-30 | $2.3m | 363,564 | | Added +209,611 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $875.9k | 136,856 | | Added +36,266 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $828.1k | 129,367 | | Reduced −2,381 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $504.3k | 78,800 | Call | Added +54,700 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $473.1k | 73,915 | | Added +14,833 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $410.2k | 64,098 | | Added +390 | | [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $282.8k | 44,193 | | Reduced −24,564 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $215.2k | 33,625 | | Unchanged | ## Recent filings [All 702 filings](/companies/lvo/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-30 | 17:00 ET | [8-K](/filings/0001213900-26-114472.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-114472 | | 2026-09-23 | 17:00 ET | [8-K](/filings/0001213900-26-102679.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-102679 | | 2026-09-22 | 21:01 ET | [SCHEDULE 13D/A](/filings/0001213900-26-102325.md) | Ownership report, active investor, amended | 0001213900-26-102325 | | 2026-08-14 | 17:05 ET | [10-Q](/filings/0001437749-26-028046.md) | Quarterly report, period 2026-06-30 | 0001437749-26-028046 | | 2026-08-12 | 08:45 ET | [8-K](/filings/0001213900-26-088072.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-088072 | | 2026-07-28 | 16:45 ET | [8-K](/filings/0001213900-26-082313.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-082313 | | 2026-07-27 | 17:24 ET | [DEF 14A](/filings/0001213900-26-081875.md) | Proxy statement, period 2026-09-17 | 0001213900-26-081875 | | 2026-06-29 | 16:06 ET | [10-K](/filings/0001437749-26-021987.md) | Annual report, period 2026-03-31 | 0001437749-26-021987 | | 2026-06-24 | 08:30 ET | [8-K](/filings/0001213900-26-071315.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-071315 | | 2026-05-13 | 21:34 ET | [SCHEDULE 13D/A](/filings/0001213900-26-056155.md) | Ownership report, active investor, amended | 0001213900-26-056155 | ## Latest annual report [Form 10-K for the fiscal year ended Mar 31, 2026](/filings/0001437749-26-021987.md), filed Jun 29, 2026. ## Forecast league Q2 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/b33bdbe3-5e34-4413-91bd-196c5afd5679) ## About the filer - CIK: 1491419 - Tickers: LVO - Exchange: Nasdaq - SIC code: 5812 Retail-Eating Places - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 17:10 ET. No prices; not investment advice.